FuturedMe is a platform focused on protein degradation, designed to create novel small molecules as potential drug candidates. FuturedMe was established utilizing CANDDY™, a proprietary drug design technology developed by the Tokyo University of Science. CANDDY™ compounds promote the degradation, rather than the inhibition, of targets associated